MITOMYCIN-C AND CAPECITABINE IN ANTHRACYCLINE AND TAXANE-PRETREATED METASTATIC BREAST CANCER (MBC). DOSE-FINDING STUDY

被引：0
|
作者：
Maisano, Roberto [1 ]
Mare, Marzia [1 ]
Caristi, Nicola [1 ]
Carboni, Rita [1 ]
Chiofalo, Giuseppe [1 ]
Priolo, Carmen [1 ]
La Torre, Francesco [1 ]
机构：
[1] Azienda Osped Univ G Martino Policlin Messina, UOC Oncol Med, Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [21] A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
    Karachaliou, N.
    Ziras, N.
    Syrigos, K.
    Tryfonidis, K.
    Papadimitraki, E.
    Kontopodis, E.
    Bozionelou, V.
    Kalykaki, A.
    Georgoulias, V.
    Mavroudis, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 169 - 176
  • [22] Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Lee, Su Jin
    Choi, Yoon La
    Park, Yeon Hee
    Kim, Seung Tae
    Cho, Eun Yoon
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 743 - 751
  • [23] Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients
    Blum, JL
    Dieras, V
    Lo Russo, PM
    Horton, J
    Rutman, O
    Buzdar, A
    Osterwalder, B
    CANCER, 2001, 92 (07) : 1759 - 1768
  • [24] Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Su Jin Lee
    Yoon La Choi
    Yeon Hee Park
    Seung Tae Kim
    Eun Yoon Cho
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 743 - 751
  • [25] A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
    N. Karachaliou
    N. Ziras
    K. Syrigos
    K. Tryfonidis
    E. Papadimitraki
    E. Kontopodis
    V. Bozionelou
    A. Kalykaki
    V. Georgoulias
    D. Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 169 - 176
  • [26] Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer
    Massacesi, Cristian
    La Cesa, Annalisa
    Marcucci, Fabiana
    Pilone, Alberta
    Rocchi, Marco B. L.
    Zepponi, Laura
    Santini, Daniele
    Tonini, Giuseppe
    Burattini, Luciano
    ONCOLOGY, 2006, 70 (04) : 294 - 300
  • [27] Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Dong, Ningning
    Wang, Mingyu
    Li, Huiqing
    Cui, Yongchun
    Guo, Qisen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1315 - 1322
  • [28] Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Tao Wang
    Shaohua Zhang
    Min Zeng
    Xinyou Lu
    Ge Shen
    Shikai Wu
    Santai Song
    Zefei Jiang
    Medical Oncology, 2012, 29 : 56 - 61
  • [29] Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Ningning Dong
    Mingyu Wang
    Huiqing Li
    Yongchun Cui
    Qisen Guo
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1315 - 1322
  • [30] Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer
    Faruk Tas
    Nese Guney
    Duygu Derin
    Hakan Camlica
    Adnan Aydiner
    Erkan Topuz
    Investigational New Drugs, 2008, 26 : 363 - 368
12345